Ropivicaine
Ropivicaine is a pharmaceutical drug with 13 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
6 of 10 finished
40.0%
4 ended early
1
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Opioid-Free Pain Protocol After Shoulder Arthroplasty
Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps
Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia
Hip Scope Fascia-iliaca (FI) Block Study
Implementation of a Pain Management Protocol for Total Knee Arthroplasty
Clinical Trials (13)
Opioid-Free Pain Protocol After Shoulder Arthroplasty
Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps
Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia
Hip Scope Fascia-iliaca (FI) Block Study
Implementation of a Pain Management Protocol for Total Knee Arthroplasty
Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane
Continuous Femoral and Tibial Nerve Blocks in TKA Patients
Labour Epidural Top-up With Warmed Ropivacaine
Femoral Nerve Block for Femur Fracture Repair in Pediatrics
Local Anaesthetic Following Hernia Repair
A Trial Comparing Adductor Canal Catheter and Intraarticular Catheter Following Primary Total Knee Arthroplasty
Trans-Abdominis Plane Block Efficacy for Post-Cesarean Section Pain
Abdominal Wall Local Anesthesia to Maximize Postoperative Pain Control After Cesarean Delivery
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13